chr3-41224633-A-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PM5PP2PP5_Very_Strong
The ENST00000349496.11(CTNNB1):c.121A>G(p.Thr41Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T41N) has been classified as Likely pathogenic.
Frequency
Genomes: not found (cov: 32)
Consequence
CTNNB1
ENST00000349496.11 missense
ENST00000349496.11 missense
Scores
9
7
3
Clinical Significance
Conservation
PhyloP100: 9.32
Genes affected
CTNNB1 (HGNC:2514): (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 15 ACMG points.
PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 2 uncertain in ENST00000349496.11
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr3-41224634-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 17587.Status of the report is criteria_provided_single_submitter, 1 stars.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CTNNB1. . Gene score misZ 3.846 (greater than the threshold 3.09). Trascript score misZ 5.712 (greater than threshold 3.09). GenCC has associacion of gene with severe intellectual disability-progressive spastic diplegia syndrome, exudative vitreoretinopathy, exudative vitreoretinopathy 7.
PP5
Variant 3-41224633-A-G is Pathogenic according to our data. Variant chr3-41224633-A-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 17580.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTNNB1 | NM_001904.4 | c.121A>G | p.Thr41Ala | missense_variant | 3/15 | ENST00000349496.11 | NP_001895.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTNNB1 | ENST00000349496.11 | c.121A>G | p.Thr41Ala | missense_variant | 3/15 | 1 | NM_001904.4 | ENSP00000344456 | P4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:5Uncertain:1Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Likely pathogenic, no assertion criteria provided | literature only | Richard Lifton Laboratory, Yale University School of Medicine | - | - - |
Uncertain significance, flagged submission | literature only | Richard Lifton Laboratory, Yale University School of Medicine | - | - - |
Hepatoblastoma Pathogenic:1Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 1999 | - - |
other, no assertion criteria provided | clinical testing | Donald Williams Parsons Laboratory, Baylor College of Medicine | May 01, 2016 | - 2: Mutations in members of targetable cancer pathways, gene families, or functional groups, regardless of tumor type; |
Desmoid tumor caused by somatic mutation Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 1999 | - - |
Desmoid tumor Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Jul 18, 2019 | - - |
Medulloblastoma;C0206711:Pilomatrixoma;C0346629:Colorectal cancer;C1140680:Ovarian cancer;C2239176:Hepatocellular carcinoma;C3554449:Severe intellectual disability-progressive spastic diplegia syndrome;C4539767:Exudative vitreoretinopathy 7 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM2_Supporting+PS4+PP2 - |
Atypical endometrial hyperplasia Other:1
association, no assertion criteria provided | research | Martignetti Lab, Icahn School of Medicine at Mount Sinai | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;T;D;T;D;D;D;D;D;T;D;D;.;T;D;D;D;T;.;T;T;D;D;.;.;.;D;T;.;D;D;T;D;.;D;T;D;D;D;D;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;.;D;.;.;.;.;T;D;D;.;.;D;.;.;.;.;D;.;D;.;.;.;.;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;M;.;M;M;M;M;M;.;M;M;.;.;M;M;M;.;.;.;.;M;M;.;.;.;M;.;.;M;M;.;M;.;M;.;M;M;M;M;M
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
.;D;.;.;D;.;.;.;D;.;D;D;.;.;D;.;.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;.;.;D
REVEL
Uncertain
Sift
Pathogenic
.;D;.;.;D;.;.;.;D;.;D;D;.;.;D;.;.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;.;.;D
Sift4G
Pathogenic
.;D;.;.;D;.;.;.;D;.;D;D;.;.;D;.;.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;.;.;D
Polyphen
P;.;P;.;P;P;P;P;P;.;P;P;.;.;P;P;P;.;.;.;.;P;P;.;.;.;P;.;.;P;P;.;P;.;P;.;P;P;P;P;P
Vest4
0.72, 0.72, 0.71, 0.73
MutPred
Loss of glycosylation at T41 (P = 0.0069);.;Loss of glycosylation at T41 (P = 0.0069);.;Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);.;Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);.;.;Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);.;.;.;.;Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);.;Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);.;Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);.;Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);Loss of glycosylation at T41 (P = 0.0069);
MVP
0.78
MPC
2.1
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at